The table below shows AGIOS PHARMACEUTICALS, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$118.92M
-$111.49M
-$99.87M
-$95.18M
-$97.73M
-$120.75M
Capital expenditure
$769.00K
$766.00K
$141.00K
$399.00K
$2.80M
$1.01M
Investing cash flow
$141.31M
$112.59M
$124.56M
$57.60M
-$26.57M
$1.87B
Dividends paid
-
-
-
-
AGIO operating cash flow (10-K history)
AGIOS PHARMACEUTICALS, INC. reported operating cash flow of -$372.98M for fiscal year 2025. That is up 4.3% from -$389.84M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $38.56M (FY 2016) to -$372.98M. Figures come from the company's audited annual reports as filed with the SEC.
